We report about the qualities of a new modified delivery clinoptilolite-based system loaded with Carmustine used for local application in chemically-induced skin tumour in mice and evaluated for it’s in vivo efficacy, using as control parameters the level of expression of bcl-2 and cox-2 proteins, comparatively to the commercially formulation in use. Here, PTGS2 is linked to skin neoplasm.